FDA grants accelerated approval to tazemetostat for follicular lymphoma which drives market during forecast year

Download Sample

Published Date: April 2023

EZH2 is a chromatin modulator or epigenetic protein that has been associated to a range of human malignancies. As a result, several EZH2 inhibitors have been discovered and are now being investigated in Phase I or II clinical trials. Despite the fact that EZH2 inhibitors could be used to treat cancer, the development process has been difficult. The prevalence of EZH2 in aggressive, triple-negative breast cancers has long been known, and experts have suggested that this was a key driving factor in the development of EZH2 inhibitors by the pharmaceutical industry.

The report "Global H2 EZInhibitors Market, By Type (3-Deazaneplanocin A (DZNep), EPZ005687, EI1, GSK126 and UNC1999), By Phase (Phase I, Phase II and Others), By End-user (Specialty Clinics, Research & Laboratories and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

Epizyme released highly encouraging interim findings for tazemetostat from two ongoing Phase II clinical trials focused on FL patients and malignant mesothelioma patients with BAP1 inactivation in June 2018.
Epizyme said in August 2018 that it will terminate a Phase II clinical trial for tazemetostat in DLBCL after interim assessments revealed that it is unlikely to succeed.

Analyst View:

The use of EZH2 inhibitors as a potential cancer treatment target is gaining traction. During the forecast period, ongoing clinical trials and studies on EZH2 inhibitors as a new cancer therapy option are expected to boost the EZH2 inhibitors market. A crucial element driving global market expansion is the increased focus on new research by government agencies and significant corporations. Due to a growth in the number of people suffering from various health problems, the global EZH2 inhibitors market is increasing.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global EZH2 Inhibitors Market, By Type (3-Deazaneplanocin A (DZNep), EPZ005687, EI1, GSK126 and UNC1999), By Phase (Phase I, Phase II and Others), By End-user (Specialty Clinics, Research & Laboratories and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-EZH2-Inhibitors-Market-4725

Key Market Insights from the report:

The Global EZH2 Inhibitors Market is segmented based on the type, phase, end-user, and region.

By Type, the Global EZH2 Inhibitors Market is segmented into 3-Deazaneplanocin A (DZNep), EPZ005687, EI1, GSK126 and UNC1999
By Phase, the market is segmented in Phase I, Phase II and Others.
By End-user, the Global EZH2 Inhibitors Market is segmented into Specialty Clinics, Research & laboratories and Others.
By Region, the Global EZH2 Inhibitors Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the EZH2 Inhibitors market.

Competitive Landscape:

The key players operating in the global EZH2 Inhibitors market includes OncoFusion, GlaxoSmithKline Plc, Constellation Pharmaceuticals, Daiichi Sankyo, Kainos Medicine, Eternity Bioscience, Epizyme and Others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning.
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period.